Viking Therapeutics filed a trade secrets lawsuit against Ascletis BioScience and other defendants on Thursday in California Southern District Court. The suit, brought by Paul Hastings, alleges that the defendants received info about the plaintiff’s thyroid drug candidate under a confidential disclosure agreement, then developed a competing drug in violation of the agreement. Counsel have not yet appeared for the defendants. The case is 3:22-cv-02062, Viking Therapeutics Inc. v. Ascletis BioScience Co. Ltd. et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.
